发布求助
文献互助 智能选刊 最新文献

Journal of the advanced practitioner in oncology最新文献

筛选
英文 中文
2022-2023 Drug Updates: Investigational Therapeutics in the Pipeline. 2022-2023 药物更新：在研治疗药物。
Journal of the advanced practitioner in oncology Pub Date : 2024-04-01 DOI: 10.6004/jadpro.2024.15.3.5
Sandra Cuellar
{"title":"2022-2023 Drug Updates: Investigational Therapeutics in the Pipeline.","authors":"Sandra Cuellar","doi":"10.6004/jadpro.2024.15.3.5","DOIUrl":"https://doi.org/10.6004/jadpro.2024.15.3.5","url":null,"abstract":"<p><p>During JADPRO Live 2023, Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP, discussed investigational therapeutic agents in the drug development pipeline. Dr. Cuellar highlighted new drug classes, novel mechanisms of action, and safety profiles that advanced practitioners should be aware of.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"15 3","pages":"182-185"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient Needs. 多发性骨髓瘤的个性化治疗：指导治疗方案，满足患者需求。
Journal of the advanced practitioner in oncology Pub Date : 2024-04-01 DOI: 10.6004/jadpro.2024.15.3.10
Beth Finley-Oliver, Rachid Baz
{"title":"Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient Needs.","authors":"Beth Finley-Oliver, Rachid Baz","doi":"10.6004/jadpro.2024.15.3.10","DOIUrl":"https://doi.org/10.6004/jadpro.2024.15.3.10","url":null,"abstract":"<p><p>At JADPRO Live 2023 in Orlando, presenters discussed selecting treatment regimens for newly diagnosed and relapsed or refractory multiple myeloma. They also provided insights on comprehensive care centered around patient preferences, treatment goals, side effect mitigation, and supportive care needs of patients with multiple myeloma.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"15 3","pages":"204-208"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shaping the Future of Oncology at JADPRO Live 2023. 在 JADPRO Live 2023 上塑造肿瘤学的未来。
Journal of the advanced practitioner in oncology Pub Date : 2024-04-01 DOI: 10.6004/jadpro.2024.15.3.1
Beth Faiman
{"title":"Shaping the Future of Oncology at JADPRO Live 2023.","authors":"Beth Faiman","doi":"10.6004/jadpro.2024.15.3.1","DOIUrl":"https://doi.org/10.6004/jadpro.2024.15.3.1","url":null,"abstract":"","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"15 3","pages":"162-163"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing the Care of Patients With Colorectal Cancer in Clinical Practice. 在临床实践中优化对结直肠癌患者的护理。
Journal of the advanced practitioner in oncology Pub Date : 2024-04-01 DOI: 10.6004/jadpro.2024.15.3.8
Mary B Morgan, Tammy Triglianos
{"title":"Optimizing the Care of Patients With Colorectal Cancer in Clinical Practice.","authors":"Mary B Morgan, Tammy Triglianos","doi":"10.6004/jadpro.2024.15.3.8","DOIUrl":"https://doi.org/10.6004/jadpro.2024.15.3.8","url":null,"abstract":"<p><p>At JADPRO Live 2023, presenters emphasized the importance of increasing colorectal cancer screening in high-risk groups, reviewed guidelines in the adjuvant and metastatic setting, and outlined clinical and molecular profiles to consider when discussing and determining treatment options with patients.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"15 3","pages":"196-199"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406322/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-2023 Drug Updates in Solid Tumors. 2022-2023 年实体瘤药物更新。
Journal of the advanced practitioner in oncology Pub Date : 2024-04-01 DOI: 10.6004/jadpro.2024.15.3.3
Lisa M Holle
{"title":"2022-2023 Drug Updates in Solid Tumors.","authors":"Lisa M Holle","doi":"10.6004/jadpro.2024.15.3.3","DOIUrl":"https://doi.org/10.6004/jadpro.2024.15.3.3","url":null,"abstract":"<p><p>At JADPRO Live 2023 in Orlando, Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP, briefed advanced practitioners on key US Food and Drug Administration approvals from late 2022 to late 2023. Dr. Holle described indications, mechanisms of action, and monitoring and management of side effects of new therapies in solid malignancies.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"15 3","pages":"170-176"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2022-2023 Drug Updates in Hematologic Malignancies. 2022-2023 年血液恶性肿瘤药物更新。
Journal of the advanced practitioner in oncology Pub Date : 2024-04-01 DOI: 10.6004/jadpro.2024.15.3.4
Rebecca L Rezac
{"title":"2022-2023 Drug Updates in Hematologic Malignancies.","authors":"Rebecca L Rezac","doi":"10.6004/jadpro.2024.15.3.4","DOIUrl":"https://doi.org/10.6004/jadpro.2024.15.3.4","url":null,"abstract":"<p><p>At JADPRO Live 2023 in Orlando, Rebecca L. Rezac, PharmD, BCOP, summarized key information on US Food and Drug Administration approvals from late 2022 to late 2023. Dr. Rezac described indications, mechanisms of action, and monitoring and management of side effects of new therapies for hematologic malignancies.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"15 3","pages":"177-181"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406321/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Prostate Cancer Patient Care in the Clinical Setting. 改善前列腺癌患者的临床护理。
Journal of the advanced practitioner in oncology Pub Date : 2024-04-01 DOI: 10.6004/jadpro.2024.15.3.9
Jessica Deinert, Leah K Shaw
{"title":"Improving Prostate Cancer Patient Care in the Clinical Setting.","authors":"Jessica Deinert, Leah K Shaw","doi":"10.6004/jadpro.2024.15.3.9","DOIUrl":"https://doi.org/10.6004/jadpro.2024.15.3.9","url":null,"abstract":"<p><p>At JADPRO Live 2023 in Orlando, presenters provided an overview of best practices in the diagnosis, classification, and management of patients with localized and metastatic prostate cancer. They covered selecting appropriate therapies based on patient clinical presentation and treatment goals, as well as managing side effects and interventions for modifiable health risks in patients with prostate cancer.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"15 3","pages":"200-203"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing Precision-Targeted Treatment for Patients With Metastatic Non-Small Cell Lung Cancer. 推进对转移性非小细胞肺癌患者的精准靶向治疗。
Journal of the advanced practitioner in oncology Pub Date : 2024-04-01 DOI: 10.6004/jadpro.2024.15.3.7
Tajuana Bradley, Beth Sandy
{"title":"Advancing Precision-Targeted Treatment for Patients With Metastatic Non-Small Cell Lung Cancer.","authors":"Tajuana Bradley, Beth Sandy","doi":"10.6004/jadpro.2024.15.3.7","DOIUrl":"https://doi.org/10.6004/jadpro.2024.15.3.7","url":null,"abstract":"<p><p>At JADPRO Live 2023, presenters discussed the implications of biomarker testing, pivotal clinical trials leading to recent FDA approvals, and evidence-based best practices for monitoring and managing adverse events associated with molecular targeted and combination therapies for patients with metastatic non-small cell lung cancer.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"15 3","pages":"170-176"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406318/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Outcomes for Women With Metastatic HER2-Positive and HER2-Low Breast Cancer. 改善转移性 HER2 阳性和 HER2 阴性乳腺癌女性患者的治疗效果。
Journal of the advanced practitioner in oncology Pub Date : 2024-04-01 DOI: 10.6004/jadpro.2024.15.3.6
Stephanie L Graff, Christine McGinn, Jeanine R Showalter
{"title":"Improving Outcomes for Women With Metastatic HER<sub>2</sub>-Positive and HER<sub>2</sub>-Low Breast Cancer.","authors":"Stephanie L Graff, Christine McGinn, Jeanine R Showalter","doi":"10.6004/jadpro.2024.15.3.6","DOIUrl":"https://doi.org/10.6004/jadpro.2024.15.3.6","url":null,"abstract":"<p><p>At JADPRO Live 2023, presenters discussed recent updates to clinical practice in metastatic HER2-positive metastatic breast cancer. During the session, they reviewed review recent FDA approvals, the clinical relevance of HER2-low status, and evidence-based practices for managing adverse events associated with novel HER2 agents.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"15 3","pages":"187-190"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Staying Abreast of New Biomarkers in Hematology/Oncology. 紧跟血液学/肿瘤学新生物标记物的步伐。
Journal of the advanced practitioner in oncology Pub Date : 2024-04-01 DOI: 10.6004/jadpro.2024.15.3.2
Andrew Guinigundo, Grace Baek
{"title":"Staying Abreast of New Biomarkers in Hematology/Oncology.","authors":"Andrew Guinigundo, Grace Baek","doi":"10.6004/jadpro.2024.15.3.2","DOIUrl":"https://doi.org/10.6004/jadpro.2024.15.3.2","url":null,"abstract":"<p><p>There has been an increasing number of approvals for targeted therapies in oncology in the past decade, changing the treatment paradigm for many solid tumors and hematologic malignancies. At JADPRO Live 2023, presenters provided an in-depth review of cancer biomarkers, including testing methodology, recommended therapies, and how advanced practitioners can integrate results into clinical decision-making.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":"15 3","pages":"164-169"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信